Published in PLoS One on March 20, 2015
Schistosomiasis vaccines: where do we stand? Parasit Vectors (2016) 0.81
Development of a schistosomiasis vaccine. Expert Rev Vaccines (2016) 0.79
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc (2007) 5.15
Human schistosomiasis. Lancet (2014) 4.00
Jump-starting the immune system: prime-boosting comes of age. Trends Immunol (2004) 2.61
Schistosomiasis. Infect Dis Clin North Am (2012) 2.01
Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res (2012) 1.91
Heterologous prime-boost vaccination. Curr Opin Immunol (2009) 1.84
Schistosomiasis: number of people receiving preventive chemotherapy in 2012. Wkly Epidemiol Rec (2014) 1.51
Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol (2005) 1.37
A cluster-randomised intervention trial against Schistosoma japonicum in the Peoples' Republic of China: bovine and human transmission. PLoS One (2009) 1.32
Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience. Acta Trop (2005) 1.27
China's sustained drive to eliminate neglected tropical diseases. Lancet Infect Dis (2014) 1.19
Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects. Expert Rev Vaccines (2009) 1.10
Human schistosomiasis resistance to praziquantel in China: should we be worried? Am J Trop Med Hyg (2011) 1.09
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity. Expert Rev Vaccines (2009) 1.06
Assessing the effect of an integrated control strategy for schistosomiasis japonica emphasizing bovines in a marshland area of Hubei Province, China: a cluster randomized trial. PLoS Negl Trop Dis (2013) 1.05
Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL/6 mice. PLoS Negl Trop Dis (2011) 1.01
[Endemic status of schistosomiasis in People's Republic of China in 2012]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (2013) 1.00
The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine (2004) 1.00
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response. Front Immunol (2013) 1.00
Immune events associated with high level protection against Schistosoma japonicum infection in pigs immunized with UV-attenuated cercariae. PLoS One (2010) 0.96
The new national integrated strategy emphasizing infection sources control for schistosomiasis control in China has made remarkable achievements. Parasitol Res (2013) 0.94
Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine (1995) 0.93
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses. J Virol (2014) 0.90
DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica. Clin Vaccine Immunol (2009) 0.89
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis. PLoS Negl Trop Dis (2013) 0.89
Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods (2009) 0.89
The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase in infected BALB/C mice. Southeast Asian J Trop Med Public Health (2004) 0.88
Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines. Vaccine (2010) 0.88
Multiple vaccinations with UV- attenuated cercariae in pig enhance protective immunity against Schistosoma japonicum infection as compared to single vaccination. Parasit Vectors (2011) 0.88
Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection. PLoS One (2012) 0.87
Protective immunity induced with 23 kDa membrane protein dna vaccine of Schistosoma japonicum Chinese strain in infected C57BL/6 mice. Southeast Asian J Trop Med Public Health (2003) 0.87
Local immune responses of the Chinese water buffalo, Bubalus bubalis, against Schistosoma japonicum larvae: crucial insights for vaccine design. PLoS Negl Trop Dis (2013) 0.87
Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents. Infect Immun (2013) 0.86
DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice. BMC Infect Dis (2013) 0.86
Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice. Vaccine (2014) 0.85
Morphofunctional characteristic of the immune system in BALB/c and C57BL/6 mice. Bull Exp Biol Med (2011) 0.85
Studies on the protective immunity of Schistosoma japonicum bivalent DNA vaccine encoding Sj23 and Sj14. Exp Parasitol (2006) 0.83
Application of praziquantel in schistosomiasis japonica control strategies in China. Parasitol Res (2013) 0.82
Gene cloning, expression and vaccine testing of Schistosoma japonicum SjFABP. Parasite Immunol (2005) 0.82
Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses. PLoS One (2013) 0.79
Vector systems for prenatal gene therapy: principles of adenovirus design and production. Methods Mol Biol (2012) 0.78
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases. Cancer Gene Ther (2012) 0.78
Seasonal dynamics of Schistosoma japonicum infection in buffaloes in the Poyang Lake region and suggestions on local treatment schemes. Vet Parasitol (2013) 0.78
Evaluation of indirect enzyme-linked immunosorbent assays and IgG avidity assays using a protein A-peroxidase conjugate for serological distinction between Brucella abortus S19-vaccinated and -infected cows. Clin Vaccine Immunol (2010) 0.78
Antitumor effect of adenoviral vector prime protein boost immunity targeting the MUC1 VNTRs. Oncol Rep (2013) 0.76